AstraZeneca

Technical Summary

Indicator	Value	Trend

Indicator	Value	Trend

Indicator	Value	Trend

Indicator	S3	S2	S1	P	R1	R2	R3

News

Reuters - 1 day ago

US FDA approves BridgeBio's drug for rare heart condition

UPDATE 2-US FDA approves BridgeBio's drug for rare heart condition Adds background in paragraphs 6-15 Nov 22 (Reuters) - The U.S. Food and Drug Administration has approved BridgeBio's BBIO.O drug for a rare and deadly heart condition, the company said on Friday, making it the first new treatment in a market dominated by Pfizer's PFE.N blockbuster Vyndaqel.

Reuters - 1 day ago

US natgas prices fall 6% on rising output, less cold forecasts

UPDATE 1-US natgas prices fall 6% on rising output, less cold forecasts US gas futures up for five weeks in a row Cold boosts spot prices to highest since Jan in US, Canada US daily gas output on track to reach to 11-week high Adds latest prices By Scott DiSavino Nov 22 (Reuters) - U.S. natural gas futures dropped about 6% in volatile trade on Friday as higher prices in recent weeks have finally prompted producers to start boosting output and on forecasts for less cold weather over the next two

Reuters - 2 days ago

Weaker pound takes FTSE 100 to best week in six months

UPDATE 1-Weaker pound takes FTSE 100 to best week in six months FTSE 100 up 1.4%, FTSE 250 up 1.1% British retail sales fall more-than-expected Pound falls to a 6-month low Flash PMI slides, first contraction in 13 months Updates to market close By Nikhil Sharma Nov 22 (Reuters) - Britain's FTSE 100 recorded its biggest weekly gain in more than six months on Friday as a slide in sterling supported dollar earners, while banks came under pressure from weak business activity data.

Reuters - 2 days ago

Weaker pound puts FTSE 100 on track for best week in six months

Weaker pound puts FTSE 100 on track for best week in six months For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window FTSE 100 up 1.1%, FTSE 250 up 1.0% Nov 22 (Reuters) - The UK's FTSE 100 was on course for its biggest weekly gain in more than six months on Friday, as a slide in sterling supported companies earning in dollars , while banks came under pressure from weak business activity data.

Reuters - 3 days ago

FTSE 100 ends up near 2-week high as sterling drops, Halma climbs

UPDATE 1-FTSE 100 ends up near 2-week high as sterling drops, Halma climbs Halma jumps after HY revenue growth CMC Markets falls most among FTSE 250 components JD Sports Fashion drops after profit warning FTSE 100 up 0.8%, FTSE 250 up 0.5% Updates to market close By Sruthi Shankar and Nikhil Sharma Nov 21 (Reuters) - The UK's blue-chip FTSE 100 rose to a near two-week high on Thursday, as a dip in sterling and rise in Halma's shares offset a slump in JD Sports after it issued a profit warning.

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.